Global stock

NYSEUSD

Ambev SA ADR

ABEV

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

62/ 100

Overall score·ABEV

Current price

3.3USD

23/10/2026

P/E, P/B

Valuation

Strong

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

Valuace ukazuje na podhodnocení: P/E 13.9 a forward P/E 12.97 naznačují nízké ocenění v porovnání se sektorem; EV/EBITDA 1.051 naznačuje výrazně nízké ocenění vzhledem k ziskovosti. Trend smeruje k podhodnocení vzhledem k EPS YoY 24.6% a solidním maržím (18.4%); nicméně vysoký dluh (DE 3.317) naznačuje rizika pro budoucí výkonnost.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 57%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Context and events

Management

Generálním ředitelem je Carlos Eduardo Klutzenschell Lisboa. CFO a vedoucím pro vztahy s investory je Guilherme Fleury de Figueiredo Ferraz Parolari. Strategie společnosti stojí na prodeji pivních a nealkoholických nápojů na latinskoamerických trzích; vedení zahrnuje také odpovědnost za dodavatelský řetězec a korporátní záležitosti.

Articles about Ambev SA ADR, in Czech (0)

No articles yet. New analyses are published daily.

§ Upcoming results

29 October 2026

in 2 days

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is Ambev SA ADR (ABEV)?

Ambev SA ADR (ABEV) is a global stock traded on NYSE. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Ambev SA ADR price today?

As of 23 October 2026, Ambev SA ADR trades at about 3.30 USD per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Ambev SA ADR?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Ambev SA ADR pay a dividend?

Ambev SA ADR either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is Ambev SA ADR a good investment in 2026?

Our AI signal currently rates Ambev SA ADR as slightly positive (score 63/100). Financial health comes out at 62/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More global stocks

Microsoft Corporation

§ How to buy Ambev SA ADR

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Slightly positive

Earnings in 2 days

On 29 October 2026 the company publishes its quarterly results. This period tends to bring large price moves — the signal below does not reflect the results yet.

News summary

Older news

Signal 26/10, 20:01

Zpráva uvádí tři důvody, proč by investoři zaměření na růst neměli přehlížet Ambev; pokud se růst potvrdí v hospodaření, mohl by podpořit výhled.

Růst ceny za 30 dní a vzestupný trend s RSI 61 podporují krátkodobé momentum. Momentum indikátor je však jen 45 a vysoká volatilita zvyšuje nejistotu.

Risks: Pokud se růst ceny zastaví nebo se nepotvrdí zlepšování růstových výsledků, optimističtější výhled by oslabil.

More about the signal

Růst ceny za 30 dní a vzestupný trend s RSI 61 podporují krátkodobé momentum. Momentum indikátor je však jen 45 a vysoká volatilita zvyšuje nejistotu.

Risks: Pokud se růst ceny zastaví nebo se nepotvrdí zlepšování růstových výsledků, optimističtější výhled by oslabil.

Signal history· 2

11/1011:0167 · Slightly positive
Analytici 9. října 2026 uvádějí, že Ambev od začátku roku vzrostla o 29,2 %, překonala spotřebitelský sektor i alkoholické nápoje a konsenzus celoročního zisku se za čtvrtletí zvýšil o 1,6 %. Pokud se růst odhadů a relativní výkonnost udrží, podporují příznivější výhled; jejich obrat by tento signál oslabil.
10/1011:0155 · Neutral
Yahoo 9. října 2026 označuje Ambev za akcii s potenciálem solidního růstu a uvádí tři důvody pro tento pohled, jejichž konkrétní obsah zde není doložen. Pokud by tyto argumenty odpovídaly trvalým výsledkům firmy, mohly by podpořit výhled; bez jejich detailů nelze sílu dopadu ověřit.

The full 90-day signal history is part of Premium.

Ask the AI

DCF valuation

A DCF model is not suitable for this asset class.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 18 of 18

Valuation score

0/ 6

3/6 tests available

1. Below DCF fair value

The complete DCF range or the current price is missing.

2. Well below DCF value

The complete DCF range or the current price is missing.

3. Price vs. the last year

86% above the 1-year low (2.50 USD to 3.43 USD), based on stored daily prices.

4. P/E vs. similar companies

No sector sample with P/E is available.

5. P/E relative to growth

PEG 2.0; a lower value means cheaper growth.

6. Analyst price target

1.2% vs. the current price, 10 analysts.

Price and fair value

no complete range

The DCF check appears once both the price and the model range are available.

Price vs analyst target

Current price

3.30 USD

Low 2.60 USDHigh 4.00 USD

Current priceAverage: 3.34 USD

DCF gap

no complete range

The DCF check appears once both the price and the model range are available.

Analyst target

+1.2%

Average target 3.34 USD vs. price 3.30 USD.

Analyst consensus

Target range

2.60 USD - 4.00 USD

Coverage

10 analysts

Analyst consensus

3 / 5

Changes 180 d

+0 / -2

EPS next year

6.9%

Revenue next year

4.8%

Valuation multiples

13.9

13.0

2.5

0.5

1.1

2.0

52-week range86% above the low

2.50 USD3.43 USD

25.0%

0.0%

18.4%

Price vs 50D7.1%

Price vs 200D14.6%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 23/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

strong

Management má solidní zázemí a prokazatelné zkušenosti s alokací kapitálu, ale veřejně dostupné informace o governance jsou omezené.

strong

Moat: Silná značková a distribuční síť poskytuje konkurenční výhodu, ale regulační prostředí a konkurenční tlaky mohou omezit růst.

Information

Type: Global stock
Symbol: ABEV
Exchange: NYSE
Currency: USD
Sector: Spotřební zboží – základní
: 13.9x
: 42.9B USD
: 3.3 %
: 0.26

§ Risk profile

Výsledky ovlivňují měnové výkyvy v Latinské Americe, inflace, kupní síla spotřebitelů a ceny surovin. Pro českého držitele ADR přidává další nejistotu kurz dolaru vůči koruně.

Ask the AI about Ambev SA ADR All signals